Cresco Labs completes US$100 million offering

On October 5, 2018, Cresco Labs, LLC (“Cresco Labs”) announced the closing its private placement offering for aggregate gross proceeds of US$100 million, making it the second largest private funding round in U.S. cannabis history. These funds provide Cresco Labs with the capital they need as they continue to expand the footprint to produce and dispense their full brand suite of medically-focused and adult-use cannabis products. Fasken advised Beacon Securities Limited, as agent, in this financing with a team that included John Sabetti, Matthew Downer and Florind Polo.